TScan Therapeutics, Inc. — All Filings
305 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-21-035470 | Sep 9, 2021 | Sep 7, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-035442 | Sep 9, 2021 | Sep 8, 2021 |
| 3 | FORM 3 SUBMISSION | 0000899243-21-035469 | Sep 9, 2021 | Sep 7, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-034610 | Aug 31, 2021 | Aug 27, 2021 |
| 10-Q | 10-Q | 0001564590-21-045079 | Aug 19, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001564590-21-045076 | Aug 19, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-096975 | Jul 28, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-029437 | Jul 22, 2021 | Jul 15, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-029440 | Jul 22, 2021 | Jul 20, 2021 |
| 4 | PRIMARY DOCUMENT | 0001638599-21-000606 | Jul 22, 2021 | Jul 20, 2021 |
| SC 13D | SC 13D | 0001104659-21-094915 | Jul 22, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-029479 | Jul 22, 2021 | Jul 20, 2021 |
| 8-K | 8-K | 0001193125-21-219696 | Jul 20, 2021 | Jul 15, 2021 |
| 424B4 | 424B4 | 0001193125-21-218024 | Jul 19, 2021 | — |
| S-8 | S-8 | 0001193125-21-216925 | Jul 16, 2021 | — |
| FWP | FWP | 0001193125-21-216710 | Jul 16, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-028652 | Jul 16, 2021 | Jul 15, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-028648 | Jul 16, 2021 | Jul 15, 2021 |
| CERT | — | 0001354457-21-000796 | Jul 15, 2021 | — |
| EFFECT | — | 9999999995-21-002781 | Jul 15, 2021 | — |
| S-1MEF | S-1MEF | 0001193125-21-216744 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028526 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028525 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028523 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028522 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028519 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028517 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028516 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028513 | Jul 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-21-028512 | Jul 15, 2021 | — |
| 3 | PRIMARY DOCUMENT | 0001638599-21-000603 | Jul 15, 2021 | — |
| 3 | PRIMARY DOCUMENT | 0001638599-21-000602 | Jul 15, 2021 | — |
| SEC STAFF LETTER | — | 9999999997-21-004135 | Jul 15, 2021 | — |
| CORRESP | — | 0001193125-21-215243 | Jul 14, 2021 | — |
| CORRESP | — | 0001193125-21-213949 | Jul 13, 2021 | — |
| CORRESP | — | 0001193125-21-213952 | Jul 13, 2021 | — |
| 8-A12B | 8-A12B | 0001193125-21-214090 | Jul 13, 2021 | — |
| UPLOAD | — | 0000000000-21-008658 | Jul 13, 2021 | — |
| S-1/A | S-1/A | 0001193125-21-212364 | Jul 12, 2021 | — |
| S-1/A | S-1/A | 0001193125-21-161996 | May 14, 2021 | — |
| S-1/A | S-1/A | 0001193125-21-151721 | May 5, 2021 | — |
| CORRESP | — | 0001193125-21-151730 | May 5, 2021 | — |
| UPLOAD | — | 0000000000-21-005643 | May 3, 2021 | — |
| CORRESP | — | 0001193125-21-145468 | Apr 30, 2021 | — |
| S-1/A | S-1/A | 0001193125-21-145429 | Apr 30, 2021 | — |
| CORRESP | — | 0001193125-21-143774 | Apr 30, 2021 | — |
| UPLOAD | — | 0000000000-21-005435 | Apr 29, 2021 | — |
| SEC STAFF LETTER | — | 9999999997-21-002242 | Apr 28, 2021 | — |
| CORRESP | — | 0001193125-21-129279 | Apr 23, 2021 | — |
| S-1 | S-1 | 0001193125-21-129264 | Apr 23, 2021 | — |